Chronic Kidney Disease 分級

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Andrew S Levey et al. Kidney Int. 2005 Jun.

Free article

Abstract

Chronic kidney disease (CKD) is a worldwide public health problem, with adverse outcomes of kidney failure, cardiovascular disease (CVD), and premature death. A simple definition and classification of kidney disease is necessary for international development and implementation of clinical practice guidelines. Kidney Disease: Improving Global Outcomes (KDIGO) conducted a survey and sponsored a controversies conference to (1) provide a clear understanding to both the nephrology and nonnephrology communities of the evidence base for the definition and classification recommended by Kidney Disease Quality Outcome Initiative (K/DOQI), (2) develop global consensus for the adoption of a simple definition and classification system, and (3) identify a collaborative research agenda and plan that would improve the evidence base and facilitate implementation of the definition and classification of CKD. The K/DOQI definition and classification were accepted, with clarifications. CKD is defined as kidney damage or glomerular filtration rate (GFR) <60 mL/min/1.73 m(2) for 3 months or more, irrespective of cause. Kidney damage in many kidney diseases can be ascertained by the presence of albuminuria, defined as albumin-to-creatinine ratio >30 mg/g in two of three spot urine specimens. GFR can be estimated from calibrated serum creatinine and estimating equations, such as the Modification of Diet in Renal Disease (MDRD) Study equation or the Cockcroft-Gault formula. Kidney disease severity is classified into five stages according to the level of GFR. Kidney disease treatment by dialysis and transplantation should be noted. Simple, uniform classifications of CKD by cause and by risks for kidney disease progression and CVD should be developed.

Similar articles

• Monitoring renal function and limitations of renal function tests.

  Prigent A. Prigent A. Semin Nucl Med. 2008 Jan;38(1):32-46. doi: 10.1053/j.semnuclmed.2007.09.003. Semin Nucl Med. 2008. PMID: 18096462 Review.

• Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.

  Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Coresh J, et al. Am J Kidney Dis. 2003 Jan;41(1):1-12. doi: 10.1053/ajkd.2003.50007. Am J Kidney Dis. 2003. PMID: 12500213

• KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.

  Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI. Inker LA, et al. Am J Kidney Dis. 2014 May;63(5):713-35. doi: 10.1053/j.ajkd.2014.01.416. Epub 2014 Mar 16. Am J Kidney Dis. 2014. PMID: 24647050 Review.

• Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.

  Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G. Levey AS, et al. Kidney Int. 2007 Aug;72(3):247-59. doi: 10.1038/sj.ki.5002343. Epub 2007 Jun 13. Kidney Int. 2007. PMID: 17568785

Cited by

• Impacts of Corticosteroid Therapy at Acute Stage of Hospital-Onset Clostridioides difficile Infections.

  Lee CC, Lee JC, Chiu CW, Tsai PJ, Ko WC, Hung YP. Lee CC, et al. Infect Drug Resist. 2022 Sep 10;15:5387-5396. doi: 10.2147/IDR.S377967. eCollection 2022. Infect Drug Resist. 2022. PMID: 36119637 Free PMC article.

• Heterogeneous Cardiovascular Profiles in CKD: ADPKD Versus non-ADPKD.

  Au EHK, Gupta A. Au EHK, et al. Kidney Int Rep. 2022 Aug 5;7(9):1930-1932. doi: 10.1016/j.ekir.2022.07.171. eCollection 2022 Sep. Kidney Int Rep. 2022. PMID: 36090505 Free PMC article. No abstract available.

• Mechanisms of ferroptosis in chronic kidney disease.

  Zhuo WQ, Wen Y, Luo HJ, Luo ZL, Wang L. Zhuo WQ, et al. Front Mol Biosci. 2022 Aug 24;9:975582. doi: 10.3389/fmolb.2022.975582. eCollection 2022. Front Mol Biosci. 2022. PMID: 36090053 Free PMC article. Review.

• Dynapenic-abdominal obesity as an independent risk factor for chronic kidney disease in postmenopausal women: a population-based cohort study.

  Choi Y, Cho J, Kim J, Bae JH, Cho EJ, Chang E, Joa KL, Kim J, Park DH, Kang JH, Kwak HB. Choi Y, et al. Menopause. 2022 Sep 1;29(9):1040-1046. doi: 10.1097/GME.0000000000002032. Epub 2022 Aug 23. Menopause. 2022. PMID: 36040432 Free PMC article.

• H-FABP Levels and Psycho-Emotional Improvement of CABG Patients during Cardiac Rehabilitation.

  Al Namat R, Al Namat D, Ciocoiu M, Hînganu MV, Șorodoc L, Șorodoc V, Foia LG, Florea L, Vlad C, Tănasă A, Constantin M, Cioloca D, Bădescu MC, Bazyani A, Felea M. Al Namat R, et al. J Cardiovasc Dev Dis. 2022 Jul 28;9(8):242. doi: 10.3390/jcdd9080242. J Cardiovasc Dev Dis. 2022. PMID: 36005406 Free PMC article.

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • ClinicalTrials.gov
  • Genetic Alliance
  • MedlinePlus Health Information

CKD patient 是什么？

肾病分几期？

肾脏病的前兆是什么？